Commercial feasibility study of a technology that multiplies blood stem cells to increase the success of transplants for cancer treatment

Project Information

BloodStemPLUS

Grant agreement ID: 728580

DOI 10.3030/728580

Project closed

EC signature date 21 May 2016

Start date 1 June 2016

End date 30 September 2016

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

GROWINGFORMULA LDA
Portugal